Your session is about to expire
← Back to Search
GAP Training for Mental Health Provider Education
N/A
Waitlist Available
Led By Maggi Price, PhD
Research Sponsored by Boston College
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-month to 12-month followup
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to improve mental health care for gender minority youth by testing an intervention to increase providers' use of gender-affirming practices. A future RCT will assess feasibility and acceptability.
Who is the study for?
This trial is for English-speaking mental health providers working with youth aged 12-25, gender minority youth (GMY) within the same age range receiving services at the pilot site, and their caregivers. Providers must be employed by the pilot site. GMY and caregivers must also identify as a gender minority.
What is being tested?
The study aims to develop and test a training program called Gender-Affirming Psychotherapy (GAP) Training for mental health professionals. It will evaluate if this training can improve care for gender minority youth through an open trial before moving on to a larger randomized controlled trial.
What are the potential side effects?
Since this intervention involves professional training rather than medical or pharmaceutical treatment, traditional side effects are not applicable. However, there may be psychological impacts from discussions during therapy that could affect participants.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6-month to 12-month followup
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-month to 12-month followup
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in provider participant assessment completion rates at 12-month followup (feasibility of conducting a larger trial)
Change in provider participant assessment completion rates at 6-month followup (feasibility of conducting a larger trial)
Change in provider participant assessment completion rates at post-training (feasibility of conducting a larger trial)
+3 moreSecondary study objectives
Client behavioral engagement by session attendance
Client behavioral engagement by session participation
Ohio Functioning Scale (client functioning)
+5 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Gender-Affirming Psychotherapy (GAP)Experimental Treatment1 Intervention
The single-arm intervention study will test an online asynchronous gender-affirming training intervention called "GAP Training."
Find a Location
Who is running the clinical trial?
National Institute of Mental Health (NIMH)NIH
2,918 Previous Clinical Trials
2,739,733 Total Patients Enrolled
Boston CollegeLead Sponsor
39 Previous Clinical Trials
48,828 Total Patients Enrolled
Maggi Price, PhDPrincipal InvestigatorBoston College School of Social Work
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- If you are currently receiving mental health services at the pilot site, you cannot be a caregiver for GMY.I am over 18, speak English, and care for someone at the pilot site who is receiving mental health services.I am a gender-minority, aged 12-25, getting mental health services, and speak English.I am a mental health care provider, over 18, and fluent in English.I identify as a gender minority (e.g., nonbinary, transgender, genderqueer).I am 18 years old or older.You can speak and understand English well.You are currently receiving mental health treatment at the study location.I am a mental health provider working with clients aged 12-25.
Research Study Groups:
This trial has the following groups:- Group 1: Gender-Affirming Psychotherapy (GAP)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Learn More About These Treatments
Share this study with friends
Copy Link
Messenger